SSA
PRAX icon

Schonfeld Strategic Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45M Buy
+10,306
New +$3.26M 0.01% 791
2025
Q3 		– Sell
-100,702
Closed -$4.23M – 2495
2025
Q2 		$4.23M Buy
100,702
+94,628
+1,558% +$3.6M 0.03% 619
2025
Q1 		$230K Sell
6,074
-37,026
-86% -$2.31M ﹤0.01% 1893
2024
Q4 		$3.32M Buy
43,100
+14,649
+51% +$1.06M 0.02% 632
2024
Q3 		$1.64M Buy
+28,451
New +$1.54M 0.01% 970
2024
Q2 		– Sell
-4,028
Closed -$246K – 2483
2024
Q1 		$246K Buy
+4,028
New +$181K ﹤0.01% 1722
2023
Q4 		– Sell
-42,170
Closed -$1.08M – 2151
2023
Q3 		$1.08M Sell
42,170
-5,815
-12% -$110K 0.01% 995
2023
Q2 		$828K Buy
47,985
+12,543
+35% +$192K 0.01% 1044
2023
Q1 		$430K Buy
35,442
+30,915
+683% +$1.3M ﹤0.01% 1226
2022
Q4 		$162K Sell
4,527
-2,940
-39% -$91.7K ﹤0.01% 2055
2022
Q3 		$254K Sell
7,467
-4,065
-35% -$203K ﹤0.01% 2191
2022
Q2 		$423K Buy
+11,532
New +$1.23M ﹤0.01% 1455
2021
Q4 		– Sell
-953
Closed -$265K – 2449
2021
Q3 		$265K Buy
+953
New +$259K ﹤0.01% 1596

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Schonfeld Strategic Advisors's PRAX Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 10,306 shares worth $3.45M. The stake represents 0.01% of the portfolio and ranks #791 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in PRAX as recently as Q2 2025.

Schonfeld Strategic Advisors first reported a position in PRAX in Q3 2021 and has held it in 13 quarters since. The position peaked at $4.23M in Q2 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Schonfeld Strategic Advisors held 10,306 shares of Praxis Precision Medicines worth $3.45M as of Q2 2026.
  • Praxis Precision Medicines was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Praxis Precision Medicines made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #791 holding.
  • Schonfeld Strategic Advisors first reported a position in Praxis Precision Medicines in Q3 2021 and has held it in 13 quarters since.
  • Schonfeld Strategic Advisors's Praxis Precision Medicines position peaked at $4.23M in Q2 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.